Latest Capital Raise News

ADX Energy has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting a recent placement settlement as a possible factor.

Almonty Industries has commenced commercial production at its flagship Sangdong Mine in South Korea and secured more than US$200 million through Nasdaq IPO and equity offerings to fund expansion projects. Despite rising revenues driven by soaring tungsten prices, the company reported a significant net loss due to non-cash derivative liabilities.

Key Petroleum Ltd has completed a modest 3% share placement but will not proceed with the remaining 13%, leaving questions over its funding strategy.

Sarytogan Graphite Limited has received over $2 million from key investor Dias Sarsenov, advancing its share placement strategy and preparing for a pivotal board appointment. Meanwhile, a significant top-up investment from the EBRD awaits shareholder approval.

Findi Limited has secured $9 million in the first tranche of its $25 million placement, enabling debt reduction and strategic shifts including the cancellation of the Nova transaction and increased ownership in Transaction Solutions International.

TMK Energy has raised $6 million in a heavily oversubscribed placement led by coal seam gas experts, aiming to accelerate drilling and commercialisation at its Gurvantes XXXV project.

Lightning Minerals has appointed Troy Brice as CEO, bringing seasoned leadership to spearhead the next phase of exploration at its Mt Turner Gold Project.

Novo Resources has officially listed over 25 million free-attaching options on the ASX, following its recent capital raising. These options, exercisable at 15 cents, underpin the company’s ongoing exploration ambitions across Western Australia and New South Wales.

Caspin Resources has successfully completed a $6 million placement and exercised options, bolstering its position in promising Australian mineral projects focused on tin and gold.

Star Minerals has completed the sale of its West Bryah copper-gold project to Catalyst Metals for $2.75 million, including cash and shares, while Catalyst also takes a strategic stake in Star Minerals. This move strengthens Star Minerals’ focus on advancing its Tumblegum South Gold Project.

Chimeric Therapeutics Limited has announced a significant 100-to-1 security consolidation affecting shares, options, and performance rights, pending shareholder approval and set for implementation in April 2026.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.